<div id="readability-page-1"><p><span>Doximity (NASDAQ:DOCS - Get Free Report)</span> was upgraded by investment analysts at Truist Financial from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a note issued to investors on Thursday, Marketbeat.com reports.</p><ul><li>3 New Year’s Resolution Stocks That Could Turn Around in 2026</li></ul><p>A number of other equities analysts have also recently weighed in on the stock. Barclays began coverage on shares of Doximity in a research report on Monday, December 8th. They issued an &#34;overweight&#34; rating and a $63.00 price objective for the company. BMO Capital Markets began coverage on Doximity in a research note on Thursday, November 13th. They issued a &#34;market perform&#34; rating and a $55.00 price target on the stock. Evercore ISI  restated an &#34;outperform&#34; rating on shares of Doximity in a research note on Thursday. Robert W. Baird lifted their price objective on Doximity from $75.00 to $80.00 and gave the stock an &#34;outperform&#34; rating in a report on Thursday, September 11th. Finally, KeyCorp cut their target price on Doximity from $75.00 to $60.00 and set an &#34;overweight&#34; rating on the stock in a research report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued  a Buy rating, five have assigned  a Hold rating and two have assigned  a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock  has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $67.28.</p><p><b>Get Our Latest Analysis on Doximity</b></p><h2>Doximity Trading Down 2.6%</h2><ul><li>Market Shift: These 3 Stocks Are Winning While Big Tech Lags</li></ul><p>NASDAQ:DOCS traded down $1.22 during trading hours on Thursday, hitting $45.27. The stock had a trading volume of 390,651 shares, compared to its average volume of 2,362,525. The company has a market cap of $8.52 billion, a PE ratio of 45.27, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. The business has a 50 day simple moving average of $49.34 and a two-hundred day simple moving average of $59.98. Doximity has a 1-year low of $43.21 and a 1-year high of $85.21. </p><p>Doximity (NASDAQ:DOCS - Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue was up 23.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 earnings per share.  Research analysts expect that  Doximity will post 0.99 EPS for the current fiscal year. </p><h2>Insider Buying and Selling</h2><ul><li>Doximity is the Facebook and LinkedIn of the Medical Community</li></ul><p>In other news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total value of $132,880.00. Following the completion of the sale, the director directly owned 19,839 shares in the company, valued at approximately $1,318,103.16. The trade was a 9.16% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction on Friday, October 10th. The stock was sold at an average price of $70.84, for a total value of $354,200.00. Following the transaction, the director owned 19,839 shares in the company, valued at $1,405,394.76. This trade represents a 20.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 31.30% of the stock is currently owned by insiders. </p><h2>Institutional Investors Weigh In On Doximity</h2><p>Institutional investors have recently modified their holdings of the business. Central Pacific Bank Trust Division lifted its holdings in  Doximity by 41.9% in the fourth quarter. Central Pacific Bank Trust Division now owns 4,752 shares of the company's stock worth $210,000 after acquiring an additional 1,402 shares during the last quarter.  Allworth Financial LP raised its position in shares of  Doximity by 369.7% during the 3rd quarter. Allworth Financial LP now owns 40,952 shares of the company's stock worth $2,996,000 after purchasing an additional 32,233 shares during the period.  Swiss Life Asset Management Ltd lifted its holdings in shares of  Doximity by 1.2% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 209,829 shares of the company's stock worth $15,349,000 after purchasing an additional 2,489 shares during the last quarter.  Tevis Investment Management lifted its holdings in shares of  Doximity by 7.9% in the 3rd quarter. Tevis Investment Management now owns 7,229 shares of the company's stock worth $529,000 after purchasing an additional 528 shares during the last quarter.  Finally, CIBC Bancorp USA Inc. acquired a new position in  Doximity during the 3rd quarter valued at approximately $908,000. Institutional investors own  87.19% of the company's stock. </p><h2>Doximity Company Profile</h2> (Get Free Report)<p>Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”  </p><p>The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Doximity</li><li>A month before the crash</li><li>Do not delete, read immediately</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>YDES Could Be 2026's Biotech Breakthrough</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RE9DUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RE9DUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Doximity Right Now?</h2><p>Before you consider Doximity, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

DOCS

<p>Truist Financial has upgraded Doximity (NASDAQ:DOCS) from a "hold" to a "buy" rating in a recent research report. Other analysts have also provided ratings, with Barclays issuing an "overweight" rating and a $63 price target, while BMO Capital Markets set a $55 target. Doximity's stock has seen fluctuations, trading down 2.6% to $45.27, with a market cap of $8.52 billion. The company reported earnings of $0.45 per share, exceeding estimates, and has a consensus target price of $67.28.</p>

Truist Financial Upgrades Doximity (NASDAQ:DOCS) to "Buy"